Evolus
EOLS
#7305
Rank
S$0.59 B
Marketcap
S$9.15
Share price
2.92%
Change (1 day)
-43.99%
Change (1 year)

Revenue for Evolus (EOLS)

Revenue in 2025 (TTM): S$0.37 Billion

According to Evolus 's latest financial reports the company's current revenue (TTM ) is S$0.37 Billion. In 2024 the company made a revenue of S$0.36 Billion an increase over the revenue in the year 2023 that were of S$0.26 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Evolus from 2017 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) S$0.37 B4.02%
2024 S$0.36 B35.61%
2023 S$0.26 B33.96%
2022 S$0.19 B47.86%
2021 S$0.13 B80.15%
2020 S$74.79 M58.86%
2019 S$47.08 M
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA